Poly Medicure Ltd
NSE:POLYMED

Watchlist Manager
Poly Medicure Ltd Logo
Poly Medicure Ltd
NSE:POLYMED
Watchlist
Price: 2 854 INR 0.4%
Market Cap: 289.2B INR
Have any thoughts about
Poly Medicure Ltd?
Write Note

Gross Margin
Poly Medicure Ltd

66.5%
Current
62%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
66.5%
=
Gross Profit
10.1B
/
Revenue
15.2B

Gross Margin Across Competitors

Country IN
Market Cap 288.2B INR
Gross Margin
67%
Country JP
Market Cap 7T JPY
Gross Margin
86%
Country CH
Market Cap 38.2B CHF
Gross Margin
55%
Country DK
Market Cap 177.1B DKK
Gross Margin
68%
Country US
Market Cap 16.3B USD
Gross Margin
70%
Country KR
Market Cap 10.3T KRW
Gross Margin
15%
Country CN
Market Cap 51B CNY
Gross Margin
72%
Country US
Market Cap 6.7B USD
Gross Margin
65%
Country CA
Market Cap 6.3B USD
Gross Margin
61%
Country UK
Market Cap 4.6B GBP
Gross Margin
56%
Country US
Market Cap 5.6B USD
Gross Margin
47%
No Stocks Found

Poly Medicure Ltd
Glance View

Market Cap
289.1B INR
Industry
Health Care

Poly Medicure Ltd., an Indian manufacturer of medical devices, is a compelling narrative of innovation driving tangible impact in healthcare. It embarked on its journey in the late 1990s, seizing on the escalating demand for high-quality medical consumables. The company carved its niche by producing a wide array of disposable medical devices like catheters, infusion therapy systems, and wound closure products, essential in medical facilities worldwide. By establishing a robust manufacturing infrastructure and leveraging economies of scale, Poly Medicure ensures competitive pricing while adhering to global quality standards. A dedication to research and development undergirds their operation, constantly pushing the envelope of modern medical technology. Revenue streams flow primarily from the sale of these innovative products to hospitals, healthcare institutions, and distributors across more than 100 countries. The company's strategic positioning in the industry is further reinforced by its commitment to sustainability and stringent adherence to regulatory compliance, which helps in sustaining long-term contracts and partnerships. The expansion of its product range and the adoption of automated manufacturing processes don't just meet but often forecast sector demands. By keeping its pulse on global health trends, Poly Medicure ensures not only stable growth in its financial graphs but also cements its authority as a cornerstone entity in the medical supplies marketplace.

POLYMED Intrinsic Value
1 334.16 INR
Overvaluation 53%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
66.5%
=
Gross Profit
10.1B
/
Revenue
15.2B
What is the Gross Margin of Poly Medicure Ltd?

Based on Poly Medicure Ltd's most recent financial statements, the company has Gross Margin of 66.5%.